Merck says experimental RSV treatment protected infants in trialBy FinMar NewsOctober 18, 2024The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on Thursday said its…
FDA approves GSK RSV vaccine for adults 50 to 59By FinMar NewsJune 7, 2024A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK’s respiratory…
